Your browser doesn't support javascript.
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
Kissler, Stephen M; Fauver, Joseph R; Mack, Christina; Olesen, Scott W; Tai, Caroline; Shiue, Kristin Y; Kalinich, Chaney C; Jednak, Sarah; Ott, Isabel M; Vogels, Chantal B F; Wohlgemuth, Jay; Weisberger, James; DiFiori, John; Anderson, Deverick J; Mancell, Jimmie; Ho, David D; Grubaugh, Nathan D; Grad, Yonatan H.
  • Kissler SM; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Fauver JR; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
  • Mack C; Real World Solutions, IQVIA, Durham, North Carolina, United States of America.
  • Olesen SW; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Tai C; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Shiue KY; Real World Solutions, IQVIA, Durham, North Carolina, United States of America.
  • Kalinich CC; Real World Solutions, IQVIA, Durham, North Carolina, United States of America.
  • Jednak S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Ott IM; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
  • Vogels CBF; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America.
  • Wohlgemuth J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
  • Weisberger J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
  • DiFiori J; Quest Diagnostics, San Juan Capistrano, California, United States of America.
  • Anderson DJ; Bioreference Laboratories, Elmwood Park, New Jersey, United States of America.
  • Mancell J; Hospital for Special Surgery, New York, New York, United States of America.
  • Ho DD; National Basketball Association, New York, New York, United States of America.
  • Grubaugh ND; Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, United States of America.
  • Grad YH; Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
PLoS Biol ; 19(7): e3001333, 2021 07.
Article in English | MEDLINE | ID: covidwho-1305572
ABSTRACT
SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Basketball Association season. For 46 individuals with acute infections, we inferred the peak viral concentration and the duration of the viral proliferation and clearance phases. According to our mathematical model, we found that viral RNA concentrations peaked an average of 3.3 days (95% credible interval [CI] 2.5, 4.2) after first possible detectability at a cycle threshold value of 22.3 (95% CI 20.5, 23.9). The viral clearance phase lasted longer for symptomatic individuals (10.9 days [95% CI 7.9, 14.4]) than for asymptomatic individuals (7.8 days [95% CI 6.1, 9.7]). A second test within 2 days after an initial positive PCR test substantially improves certainty about a patient's infection stage. The effective sensitivity of a test intended to identify infectious individuals declines substantially with test turnaround time. These findings indicate that SARS-CoV-2 viral concentrations peak rapidly regardless of symptoms. Sequential tests can help reveal a patient's progress through infection stages. Frequent, rapid-turnaround testing is needed to effectively screen individuals before they become infectious.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Replication / RNA, Viral / Virus Shedding / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Country/Region as subject: North America Language: English Journal: PLoS Biol Journal subject: Biology Year: 2021 Document Type: Article Affiliation country: Journal.pbio.3001333

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Replication / RNA, Viral / Virus Shedding / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Country/Region as subject: North America Language: English Journal: PLoS Biol Journal subject: Biology Year: 2021 Document Type: Article Affiliation country: Journal.pbio.3001333